Stroke
Conditions
Brief summary
The goal of this type of study: clinical trial is to assess K-OCS clinical utility in participant population. The main aims: validate the reliability and validity of the Korean version of the Oxford Cognitive Screen (K-OCS) analyze its sensitivity, specificity, and diagnostic accuracy, and compare its examination participation rates with existing assessment tools to determine the effectiveness of K-OCS in detecting post-stroke cognitive impairment.
Interventions
None listed
Sponsors
Bundang CHA Hospital
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
20 Years to No maximum
Inclusion criteria
For stroke patients 1. Inclusion Criteria: * Adults over 20 years of age * More than 72 hours elapsed since the onset of stroke symptoms. * After hearing a detailed explanation of this study and fully understanding it, the subject or legal representative voluntarily decides to participate and agrees in writing to observe the precautions * Involved individuals diagnosed with stroke by neurology and rehabilitation medicine specialists based on data acquired from 3T GE Signa System (General Electric, Milwaukee, WI), brain magnetic resonance imaging (MRI), and computed tomography (CT). 2.
Exclusion criteria
* Who cannot meet the inclusion criteria For healthy voluteers 1. Inclusion Criteria: * Over 20 years of age * A person who is performing an independent daily life * A person who voluntarily decides to participate and agrees in writing to abide by the precautions after hearing a detailed explanation of this study and fully understanding it 2.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Measurement of K-OCS | Between November 2020 and April 2022 | Measurement of k-ocs is a process of validating K-OCS and assess its clinical utility |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Measurement of Korean version of mini-mental state examination (K-MMSE) | Between November 2020 and April 2022 | K-MMSE is a measurement of cognitive level. Any score of 24 or more (out of 30) indicates a normal cognition. Below this, scores can indicate severe(≤9 points), moderate (10-18 points) or mild (19-23 points) cognitive impairment. The raw score may also need to be corrected for educational attainement and age. |
| Measurement Korean Version of the Oxford cognitive screen (K-OCS) | Between November 2020 and April 2022 | OCS is an assessment of major cognitive domains of memory, language, number, praxis, executive functions and attention. |
| Measurement of national institute of health care stroke scale (NIHSS) | Between November 2020 and April 2022 | NIHSS is a measurement for assessing the severity of stroke patients. The scale is made up of 11 different elements that evaluate specific ability. The score for each ability is a number between 0 and 4, 0 being normal functioning and 4 being completely impaired. 42 is the highest score possible, the higher the score, the more impaired a stroke patient is. |
| Measurement of fuctional independence meausure (FIM) | Between November 2020 and April 2022 | FIM is a measurment to evaluate the funciontional status. FIS is an 18-item including functional capability in six areas of self-care, continence, mobility, transfers, communication and cognition. Each of the 18 items are graded on a scale of 1-7, based on the level of independence in that item |
Countries
South Korea
Contacts
Primary ContactEunyoung Cho
Outcome results
None listed